Valuation (90%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 9.77 | N/A |
| PEG Ratio (TTM) | 0.20 | N/A |
| P/S Ratio (TTM) | 1.15 | N/A |
| P/B Ratio (TTM) | 1.42 | N/A |
| P/FCF Ratio (TTM) | 7.99 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.24 | N/A |
| Price to 5YR AVG FCF Ratio | 8.42 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 3.25% | N/A |
| ROE (TTM) | 14.84% | N/A |
| Net Profit Margin (TTM) | 11.70% | N/A |
| ROIC 5YR AVG | -58.02% | N/A |
Growth (90%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 137.80% | 101.38% | 48.40% |
| Revenue | 5.44% | 16.50% | 5.16% |
| Net Income | 131.67% | 104.23% | 48.92% |
| Cash Flow | 21.44% | 20.12% | 4.97% |
Health (63%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.23 | N/A |
| Quick Ratio (TTM) | 2.23 | N/A |
| D/E Ratio (TTM) | 0.31 | N/A |
| Interest Coverage (TTM) | 9.72 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 1.09 | N/A |
| LTL to 5YR AVG FCF | 1.45 | N/A |
| Shares Outstanding Growth 5YR AVG | -0.75% | N/A |